Overview

At a Glance

  • Unifying platform approach yielding a diversified, balanced pipeline targeting critical unmet medical needs
  • Proven internal center of excellence (PCT) with bicoastal facilities innovating discovery, development, manufacturing and delivery of cell-based therapies
  • Highly experienced management and scientific team

Stock Quote

CLBS
Exchange NASDAQ (US Dollar)
Price
$1.61
Change (%)
-0.09 (-5.29%)
Data as of Sep 2, 12:48PM EDT
Minimum 20 minute delay for quote.

Downloads

Corporate Profile PDF

Corporate Presentation PDF